Blincyto (blinatumomab)

Blinatumomab (trade name Blincyto, previously known as AMG103 and MT103) is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia...Wikipedia

 

 

Manufacturer's Website: Blincyto

 

 

 

Average retail cost: $3,726/dose

Search Terms: Blincyto, blinatumomab, Philadelphia chromosome-negative, lymphoblastic leukemia